What I'm saying is that at this point CPT codes are a 'shiny object' distraction. Firstly...successful LymPro patient clinicals, THEN use by drug companies who do not receive reimbursement for patient clinical drug trials for non-life threatening diseases and only then, and only maybe if there are AD treatments, do private practicioners start using the test.
Those are very likely the reasons that there is no acceptable LymPro 'deal' within Gerald's grasp...at this time.
Potential LymPro suitors/JV partners would/have likely beat Gerald severely about the head and shoulders over those exact points.
What I'm saying is that at this point CPT codes are a 'shiny object' distraction. Firstly...successful LymPro patient clinicals, THEN use by drug companies who do not receive reimbursement for patient clinical drug trials for non-life threatening diseases and only then, and only maybe if there are AD treatments, do private practicioners start using the test.
Those are very likely the reasons that there is no acceptable LymPro 'deal' within Gerald's grasp...at this time.
Potential LymPro suitors/JV partners would/have likely beat Gerald severely about the head and shoulders over those exact points.